AYTU Insider Trading
Insider Ownership Percentage: 4.90%
Insider Buying (Last 12 Months): $19,500.00
Insider Selling (Last 12 Months): $0.00
Aytu BioPharma Share Price & Price History
Current Price: $2.27
Price Change: +0.30 (1.20%)
As of 02/24/2026 05:00 PM ET
Aytu BioPharma Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/28/2025 | Joshua R Disbrow | CEO | Buy | 15,000 | $1.30 | $19,500.00 | 86,591 | |
| 6/16/2023 | Greg Pyszczymuka | Insider | Buy | 12,000 | $1.87 | $22,440.00 | 21,935 | |
| 6/14/2023 | Joshua R Disbrow | CEO | Buy | 14,000 | $1.86 | $26,040.00 | 71,591 | |
Aytu BioPharma Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/18/2026 | XTX Topco Ltd | 25,860 | $67K | 0.0% | N/A | 0.241% |  |
| 2/17/2026 | Diadema Partners LP | 305,788 | $0.80M | 0.1% | +12.1% | 2.850% |  |
| 2/17/2026 | Persistent Asset Partners Ltd | 79,415 | $0.21M | 0.1% | +27.2% | 0.740% |  |
| 2/17/2026 | Rothschild Wealth LLC | 20,000 | $52K | 0.0% | N/A | 0.186% |  |
| 2/12/2026 | DRW Securities LLC | 29,368 | $76K | 0.0% | N/A | 0.274% |  |
| 2/12/2026 | Renaissance Technologies LLC | 89,623 | $0.23M | 0.0% | -5.8% | 0.835% |  |
| 1/23/2026 | Bellevue Asset Management LLC | 25,013 | $65K | 0.0% | N/A | 0.245% |  |
| 1/21/2026 | Daytona Street Capital LLC | 10,000 | $26K | 0.0% | N/A | 0.098% |  |
| 1/16/2026 | FNY Investment Advisers LLC | 31,600 | $82K | 0.0% | +24,207.7% | 0.310% |  |
| 11/14/2025 | Two Sigma Investments LP | 68,736 | $0.13M | 0.0% | +96.2% | 0.675% |  |
| 11/12/2025 | Dimensional Fund Advisors LP | 30,964 | $58K | 0.0% | N/A | 0.304% |  |
| 11/10/2025 | Persistent Asset Partners Ltd | 62,452 | $0.12M | 0.1% | N/A | 0.613% |  |
| 8/15/2025 | AWM Investment Company Inc. | 619,874 | $1.35M | 0.2% | N/A | 6.903% |  |
| 8/13/2025 | Stonepine Capital Management LLC | 812,676 | $1.77M | 1.7% | +75.3% | 9.053% |  |
| 7/30/2025 | FNY Investment Advisers LLC | 35,921 | $78K | 0.0% | N/A | 0.400% |  |
| 7/15/2025 | Kanen Wealth Management LLC | 573,358 | $1.25M | 0.5% | N/A | 6.385% |  |
| 5/15/2025 | Armistice Capital LLC | 57,597 | $69K | 0.0% | -61.6% | 0.934% |  |
| 5/14/2025 | Stonepine Capital Management LLC | 463,721 | $0.56M | 0.5% | +13.8% | 7.516% |  |
| 2/17/2025 | Stonepine Capital Management LLC | 407,549 | $0.69M | 0.6% | -18.6% | 6.627% |  |
| 11/14/2024 | Stonepine Capital Management LLC | 500,958 | $1.18M | 0.7% | +6.0% | 8.147% |  |
| 8/15/2024 | Armistice Capital LLC | 252,000 | $0.74M | 0.0% | N/A | 4.220% |  |
| 8/9/2024 | Dimensional Fund Advisors LP | 23,551 | $69K | 0.0% | +54.5% | 0.394% |  |
| 8/16/2023 | Stonepine Capital Management LLC | 472,369 | $0.76M | 0.3% | N/A | 12.497% |  |
| 8/11/2023 | Stonepine Capital Management LLC | 472,369 | $0.76M | 0.3% | N/A | 12.497% |  |
| 2/7/2023 | Commonwealth Equity Services LLC | 309,558 | $58K | 0.0% | +47.7% | 9.922% |  |
| 11/4/2022 | Prudential Financial Inc. | 145,550 | $27K | 0.0% | +257.2% | 0.233% |  |
| 11/16/2021 | Schonfeld Strategic Advisors LLC | 20,200 | $58K | 0.0% | -22.8% | 0.073% |  |
| 11/12/2021 | Renaissance Technologies LLC | 660,604 | $1.90M | 0.0% | +38.4% | 2.398% |  |
| 11/9/2021 | BlackRock Inc. | 498,952 | $1.44M | 0.0% | +3.2% | 1.811% |  |
Data available starting January 2016
Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Read More on Aytu BioPharma
Volume
31,675 shs
Average Volume
61,823 shs
Market Capitalization
$24.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.37
Who are the company insiders with the largest holdings of Aytu BioPharma?
Who are the major institutional investors of Aytu BioPharma?
Which major investors are selling Aytu BioPharma stock?
Within the last quarter, AYTU stock was sold by these institutional investors:
- Renaissance Technologies LLC
Which major investors are buying Aytu BioPharma stock?
Within the last quarter, AYTU stock was acquired by institutional investors including:
- Diadema Partners LP
- FNY Investment Advisers LLC
- DRW Securities LLC
- XTX Topco Ltd
- Bellevue Asset Management LLC
- Rothschild Wealth LLC
- Persistent Asset Partners Ltd
- Daytona Street Capital LLC